Why the study?
Scaled reptiles naturally encounter orthoflaviviruses and sometimes resist infection, prompting investigation into antiviral defenses encoded in reptile genomes.
Reptilian genomes contain harbiTRIM variants with distinct antiviral properties, representing a novel reservoir of antiviral defenses against orthoflaviviruses.
Answers are grounded in this paper and cite their sources.
HarbiTRIM restricts dengue in human cells; leaves open translation to clinical antivirals.
Scaled reptiles (squamates) naturally encounter orthoflaviviruses and in some cases robustly resist infection. To identify antiviral defenses encoded in reptile genomes, we screened a green iguana cDNA library and discovered a reptilian TRIM-family E3 ubiquitin ligase that reduces dengue virus replication ∼10,000-fold in human cells. Experimental evolution identified orthoflavivirus capsid as a key determinant of harbiTRIM-mediated restriction, revealing a convergence of TRIMs on viral capsids as targets during viral infections. HarbingerTRIM is situated near an endogenized Harbinger transposon in various copy numbers in squamate genomes. Analysis of a sampling of reptile harbiTRIM variants revealed distinct antiviral properties, highlighting the immune diversity present in non-mammal animal genomes as a largely untapped reservoir of antiviral defenses.
No takes yet. Share an insight, caveat, or question.
Boys et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: